Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 14, 2024; 30(6): 565-578
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.565
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.565
Figure 7 JOSD2 enhances the activation of phosphorylation pathways in esophageal squamous cell carcinoma.
A: Western blotting showing that JOSD2 knockdown in esophageal squamous cell carcinoma (ESCC) cells decreased the phosphorylation of ERK1/2 and AKT; B: Western blotting showing that JOSD2 overexpression in ESCC cells activated the MAPK/ERK and PI3K/AKT signaling pathways.
- Citation: Wang WP, Shi D, Yun D, Hu J, Wang JF, Liu J, Yang YP, Li MR, Wang JF, Kong DL. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma. World J Gastroenterol 2024; 30(6): 565-578
- URL: https://www.wjgnet.com/1007-9327/full/v30/i6/565.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i6.565